Sandrine Parent

Title: Sandrine Parent: Innovator in Engineered Stem Cell Technology

Introduction

Sandrine Parent is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of biomedical engineering, particularly in the development of engineered stem cells. Her innovative work focuses on creating cellular products that can be utilized in treating cardiac conditions.

Latest Patents

Sandrine Parent holds a patent for "Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof." This patent describes a cardiac explant-derived stem cell (EDC) that includes a gene encoding an intermediate-conductance Ca-activated K channel. The gene facilitates the overexpression of this channel, which is crucial for modulating bioelectric properties. The patent also outlines methods for producing engineered EDCs and compositions for treating damaged myocardium, utilizing extracellular vesicles isolated from cultures of these engineered cells.

Career Highlights

Throughout her career, Sandrine has worked with esteemed organizations such as the Ottawa Heart Institute Research Corporation and the Institut De Cardiologie De Montréal. Her research has focused on advancing the understanding and application of stem cell technology in cardiac health.

Collaborations

Sandrine has collaborated with notable colleagues, including Patrick Vigneault and Darryl Davis, to further her research and innovations in the field of stem cell therapy.

Conclusion

Sandrine Parent's work in engineered stem cells represents a significant advancement in medical science, particularly for cardiac treatment. Her innovative approaches and collaborations continue to pave the way for future developments in regenerative medicine.